Pamela Connealy - Mar 31, 2025 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
CFO & COO
Signature
/s/ Pamela Connealy
Stock symbol
PYXS
Transactions as of
Mar 31, 2025
Transactions value $
$405,880
Form type
4
Date filed
4/2/2025, 08:56 AM
Previous filing
Dec 23, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PYXS Stock Option (Right to Buy) Award $406K +414K $0.98 414K Mar 31, 2025 Common Stock 414K $0.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest over four years, with 25% vesting on the first anniversary of March 31, 2025 and the remainder vesting in 36 equal monthly installments thereafter subject to the reporting person's continued emmployment through the applicable vesting date.